NZ184281A - Hydantoin derivatives and pharmaceutical compositions - Google Patents
Hydantoin derivatives and pharmaceutical compositionsInfo
- Publication number
- NZ184281A NZ184281A NZ184281A NZ18428177A NZ184281A NZ 184281 A NZ184281 A NZ 184281A NZ 184281 A NZ184281 A NZ 184281A NZ 18428177 A NZ18428177 A NZ 18428177A NZ 184281 A NZ184281 A NZ 184281A
- Authority
- NZ
- New Zealand
- Prior art keywords
- pharmaceutical compositions
- hydantoin derivatives
- hydantoin
- derivatives
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
- C07D233/78—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2287776 | 1976-06-03 | ||
| GB5034076 | 1976-12-02 | ||
| GB1214577 | 1977-03-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ184281A true NZ184281A (en) | 1980-04-28 |
Family
ID=27256793
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ184281A NZ184281A (en) | 1976-06-03 | 1977-06-02 | Hydantoin derivatives and pharmaceutical compositions |
Country Status (12)
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1602188A (en) * | 1977-12-01 | 1981-11-11 | Wellcome Found | Hydantoin derivatives |
| JPS5463083A (en) * | 1977-09-05 | 1979-05-21 | Wellcome Found | Organism active nitrogen compound |
| DK543178A (da) * | 1977-12-01 | 1979-06-02 | Wellcome Found | Thiodydantoinderivater |
| DE2963795D1 (en) * | 1978-01-23 | 1982-11-11 | Beecham Group Plc | Hydantoins and thiohydantoins, method for their preparation and pharmaceutical compositions containing them |
| EP0004723A1 (en) * | 1978-03-30 | 1979-10-17 | Beecham Group Plc | Deoxyhydantoins, processes for their preparation and pharmaceutical compositions containing them |
| GB1599740A (en) * | 1978-05-31 | 1981-10-07 | Wellcome Found | Hydantoin derivatives |
| AU4778279A (en) * | 1978-06-15 | 1979-12-20 | Beecham Group Limited | Prostaglandin analogues |
| IL57504A0 (en) * | 1978-06-15 | 1979-10-31 | Beecham Group Ltd | Prostagandin analogues,their preparation and pharmaceutical compositions containing |
| US4294972A (en) * | 1978-06-15 | 1981-10-13 | Beecham Group Limited | 1,2-Disubstituted oxo triazolidine |
| EP0006352A1 (en) * | 1978-06-15 | 1980-01-09 | Beecham Group Plc | Hydantoins and thiohydantoins, process for their preparation and pharmaceutical compositions containing them |
| IL59065A0 (en) * | 1979-01-18 | 1980-05-30 | Beecham Group Ltd | Hydantoin derivatives,their preparation pharmaceutical compositons containing them |
| GB2050371A (en) * | 1979-05-09 | 1981-01-07 | Wellcome Found | Optically active hydantoin derivatives and pharmaceutical formulations containing them |
| US4684735A (en) * | 1985-07-01 | 1987-08-04 | Stauffer Chemical Company | Promotion of raney nickel hydrogenation catalyst |
| JP3022878U (ja) * | 1995-08-18 | 1996-04-02 | 有限会社春江加工 | ミニディスク用ケース |
| BR0214437A (pt) | 2001-11-30 | 2004-10-13 | Lilly Co Eli | Composto, composição farmacêutica, métodos de modular um receptor ativado por proliferador de peroxissoma, de tratar e de prevenir a diabete melito, e de tratar a sìndrome x, e doenças cardiovasculares em um mamìfero, e, uso de um composto |
| JP2006527189A (ja) * | 2003-06-06 | 2006-11-30 | アラーガン、インコーポレイテッド | ピペリジニルプロスタグランジンｅ類似体 |
| US7179820B2 (en) * | 2003-06-06 | 2007-02-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1524818A (en) * | 1974-11-29 | 1978-09-13 | Beecham Group Ltd | 12-azaprostaglandins |
-
1977
- 1977-06-02 NL NL7706064A patent/NL7706064A/xx not_active Application Discontinuation
- 1977-06-02 SE SE7706428A patent/SE446336B/xx unknown
- 1977-06-02 CH CH679677A patent/CH645631A5/de not_active IP Right Cessation
- 1977-06-02 FI FI771763A patent/FI71930C/fi not_active IP Right Cessation
- 1977-06-02 FR FR7716849A patent/FR2362839A1/fr active Granted
- 1977-06-02 NZ NZ184281A patent/NZ184281A/xx unknown
- 1977-06-02 DK DK244577A patent/DK244577A/da not_active Application Discontinuation
- 1977-06-02 ES ES459412A patent/ES459412A1/es not_active Expired
- 1977-06-02 HU HU77WE560A patent/HU183046B/hu unknown
- 1977-06-02 DE DE19772724948 patent/DE2724948A1/de not_active Ceased
- 1977-06-02 CA CA000280455A patent/CA1176261A/en not_active Expired
- 1977-06-02 JP JP6525277A patent/JPS52151168A/ja active Granted
-
1978
- 1978-06-01 ES ES470428A patent/ES470428A1/es not_active Expired
-
1979
- 1979-02-28 ES ES478156A patent/ES478156A1/es not_active Expired
- 1979-06-28 ES ES482010A patent/ES482010A1/es not_active Expired
-
1980
- 1980-03-25 ES ES489883A patent/ES8103057A1/es not_active Expired
-
1982
- 1982-05-19 SE SE8203161A patent/SE8203161L/sv not_active Application Discontinuation
-
1984
- 1984-02-07 CH CH57784A patent/CH646426A5/de not_active IP Right Cessation
- 1984-02-07 CH CH576/84A patent/CH647511A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2362839A1 (fr) | 1978-03-24 |
| NL7706064A (nl) | 1977-12-06 |
| JPS6222986B2 (US06168776-20010102-C00041.png) | 1987-05-20 |
| SE7706428L (sv) | 1977-12-04 |
| SE8203161L (sv) | 1982-05-19 |
| ES489883A0 (es) | 1981-02-16 |
| ES459412A1 (es) | 1978-11-01 |
| DK244577A (da) | 1977-12-04 |
| CA1176261A (en) | 1984-10-16 |
| ES478156A1 (es) | 1979-11-01 |
| CH645631A5 (en) | 1984-10-15 |
| JPS52151168A (en) | 1977-12-15 |
| ES482010A1 (es) | 1980-08-16 |
| SE446336B (sv) | 1986-09-01 |
| DE2724948A1 (de) | 1977-12-15 |
| ES8103057A1 (es) | 1981-02-16 |
| FR2362839B1 (US06168776-20010102-C00041.png) | 1980-02-01 |
| CH647511A5 (en) | 1985-01-31 |
| HU183046B (en) | 1984-04-28 |
| ES470428A1 (es) | 1979-09-01 |
| CH646426A5 (en) | 1984-11-30 |
| FI71930C (fi) | 1987-03-09 |
| FI71930B (fi) | 1986-11-28 |
| FI771763A (fi) | 1977-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH13569A (en) | Imidazolidine derivatives and pharmaceutical compositions containing the same | |
| NZ185986A (en) | 2-oxa-bicyclic prostag-landins and pharmaceutical compositions | |
| NZ183150A (en) | 7-aminothiazolyl-iminoa-cetamido-cephalosporin derivatives and pharmaceutical compositions | |
| IL53094A0 (en) | New hydantoin derivatives their preparation and pharmaceutical compositions containing them | |
| NZ183551A (en) | Aminochromanols and pharmaceutical compositions containingthem | |
| NZ184281A (en) | Hydantoin derivatives and pharmaceutical compositions | |
| NZ183134A (en) | I-i-(3-aryloxy-2-hydroxypropyl)-4-piperidyl-3-aryl-imid-azolidin or hexahydropyrimidin-2-ones; and pharmaceutical compositions | |
| NZ184428A (en) | N-acyl-l-alanyl-aminoacyl-amides untermediates and pharmaceutical compositions | |
| NZ184755A (en) | 2-benzylpyrrolidine derivatives and pharmaceutical compositions | |
| NZ186119A (en) | 7-alkoxycarbonyl-6-alkyl/halo-17-hydoxy-3-oxo-17 -pregn-4-ene-21-carboxylic acid derivatives and pharmaceutical compositions | |
| NZ184912A (en) | 2-phenylamino-imidazolines and pharmaceutical compositions | |
| NZ185642A (en) | Morphanthridine derivatives and pharmaceutical compositions | |
| NZ184103A (en) | Fenzodioxole derivatives and pharmaceutical compositions | |
| NZ184102A (en) | Derivatives of benzenesulphonylurea,and pharmaceutical compositions | |
| NZ184808A (en) | Heterocyclic compounds and pharmaceutical compositions | |
| NZ183549A (en) | Amidinopencillanoyloxy-alkyl-amoxycillinates and pharmaceutical compositions | |
| NZ186059A (en) | 3-sulphamoyl-5-pyrrolylal-kylbenzoic acid derivatives and pharmaceutical compositions | |
| NZ186410A (en) | Imidazole derivatives and pharmaceutical compositions | |
| PH12641A (en) | Benzodiazepines derivatives and pharmaceutical compositions thereof | |
| NZ185824A (en) | Imidazole derivatives and pharmaceutical compositions | |
| NZ184367A (en) | 2-vinyl-chromone derivatives and pharmaceutical compositions | |
| NZ185295A (en) | 9-chloroprednisolone derivatives and pharmaceutical compositions | |
| NZ184084A (en) | 2-carboxyalkyl-pyrrolid-in or piperidin-one or-dione derivatives and pharmaceutical compositions | |
| NZ183756A (en) | Bis-penicillanoyloxy-alkanes and pharmaceutical compositions | |
| AU2507777A (en) | Naphthyl derivatives and pharmaceutical compositions |